Dinah Foer

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Chronic Obstructive Pulmonary Disease

Electronic Health Record

Top Venues

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

American journal of respiratory and critical care medicine

Journal of personalized medicine

The Journal of asthma : official journal of the Association for the Care of Asthma

This page only lists publications with an associated author ORCID identifier.

Publications

Alex McDowell, Vicki Fung, David W Bates, Dinah Foer
Factors Associated with Completeness of Sex and Gender Fields in Electronic Health Records. LGBT health (2024)
Dinah Foer, Patrick Emanuel Beeler, Jing Cui, William E Snyder, Mona Mashayekhi, Hui Nian, James M Luther, Elizabeth W Karlson, Joshua A Boyce, Katherine N Cahill
Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Dinah Foer, Taneem Amin, Jun Nagai, Yumi Tani, Chunli Feng, Tao Liu, Dawn C Newcomb, Juying Lai, Hiroaki Hayashi, William E Snyder, Alanna McGill, Anabel Lin, Tanya M Laidlaw, Kevin D Niswender, Joshua A Boyce, Katherine N Cahill
Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease. Journal of immunology (Baltimore, Md. : 1950) (2023)
Dinah Foer, Patrick Emanuel Beeler, Jing Cui, William E Snyder, Mona Mashayekhi, Hui Nian, James M Luther, Elizabeth W Karlson, Joshua A Boyce, Katherine N Cahill
Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Dinah Foer, Zachary H Strasser, Jing Cui, Katherine N Cahill, Joshua A Boyce, Shawn N Murphy, Elizabeth W Karlson
Association of GLP-1 Receptor Agonists with COPD Exacerbations Among Patients with Type 2 Diabetes. American journal of respiratory and critical care medicine (2023)
Dinah Foer, Zachary H Strasser, Jing Cui, Katherine N Cahill, Joshua A Boyce, Shawn N Murphy, Elizabeth W Karlson
Reply to: A Daunting and Challenging Task to Prove the Effectiveness of Reducing Acute Exacerbation in COPD Patients with Type 2 Diabetes by GLP-1 Receptor Agonists. American journal of respiratory and critical care medicine (2023)
Dinah Foer, Patrick Emanuel Beeler, Jing Cui, William E Snyder, Mona Mashayekhi, Hui Nian, James M Luther, Elizabeth W Karlson, Joshua A Boyce, Katherine N Cahill
Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Dinah Foer, Patrick Emanuel Beeler, Jing Cui, William E Snyder, Mona Mashayekhi, Hui Nian, James M Luther, Elizabeth W Karlson, Joshua A Boyce, Katherine N Cahill
Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Dinah Foer, Patrick Emanuel Beeler, Jing Cui, William E Snyder, Mona Mashayekhi, Hui Nian, James M Luther, Elizabeth W Karlson, Joshua A Boyce, Katherine N Cahill
Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Dinah Foer, David Rubins, Anthony N Almazan, Paige G Wickner, David Westfall Bates, Ole-Petter Riksfjord Hamnvik
Gender Reference Use in Spirometry for Transgender Patients. Annals of the American Thoracic Society 18 (3) (2021)
Dinah Foer, Patrick E Beeler, Jing Cui, Elizabeth W Karlson, David W Bates, Katherine N Cahill
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists. American journal of respiratory and critical care medicine 203 (7) (2021)
Dinah Foer, Katherine N Cahill
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352. Diabetes care 44 (8) (2021)
Dinah Foer, Patrick E Beeler, Jing Cui, Elizabeth W Karlson, David W Bates, Katherine N Cahill
Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes. American journal of respiratory and critical care medicine 203 (7) (2021)
Seung Han Baek, Dinah Foer, Katherine N Cahill, Elliot Israel, Enrico Maiorino, Annika Röhl, Joshua A Boyce, Scott T Weiss
Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study. Journal of personalized medicine 11 (4) (2021)
Robert S Rudin, Nabeel Qureshi, Dinah Foer, Anuj K Dalal, Maria O Edelen
Toward an asthma patient-reported outcome measure for use in digital remote monitoring. The Journal of asthma : official journal of the Association for the Care of Asthma (2021)
Dinah Foer, David M Rubins, Anthony Almazan, Kit Chan, David W Bates, Ole-Petter R Hamnvik
Challenges with Accuracy of Gender Fields in Identifying Transgender Patients in Electronic Health Records. Journal of general internal medicine 35 (12) (2019)